Skip to main content
Clinical Trials/NCT02214316
NCT02214316TerminatedPhase 1

IVF in Pediatric Concussion

Washington University School of Medicine1 site in 1 country2 target enrollmentStarted: October 2015Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Terminated
Enrollment
2
Locations
1
Primary Endpoint
Postconcussive symptoms

Study Overview

Brief Summary

Children with concussion may improve with intravenous fluids.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
6 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • History of acute concussion

Exclusion Criteria

  • Other significant medical illness

Outcomes

Primary Outcomes

Postconcussive symptoms

Time Frame: 3 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

IVF in Pediatric Concussion | Clinical Trial